StemCells, Inc. (Nasdaq: STEM) entered into an agreement with the California Institute for Regenerative Medicine (CIRM) under which CIRM will ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE